Xanthinol Nicotinate CAS 437-74-1
Identification
CAS Number
437-74-1
Name
Xanthinol Nicotinate
Synonyms
1492
207-115-7 [EINECS]
3-Pyridinecarboxylic acid compd with 3,7-dihydro-7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]-1,3-dimethyl-1H-purine-2,6-dione (1:1)
3-Pyridinecarboxylic acid, compd. with 3,7-dihydro-7-(2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl)-1,3-dimethyl-1H-purine-2,6-dione (1:1)
3-Pyridinecarboxylic acid, compd. with 3,7-dihydro-7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]-1,3-dimethyl-1H-purine-2,6-dione (1:1) [ACD/Index Name]
437-74-1 [RN]
7-[2-Hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]theophylline compd with nicotinic acid
7-[3-[N-(2-Hydroxyethyl)amino]-2-hydroxypropyl]theophylline nicotinate
8G60H12X2D
Acide nicotinique – 7-{2-hydroxy-3-[(2-hydroxyéthyl)(méthyl)amino]propyl}-1,3-diméthyl-3,7-dihydro-1H-purine-2,6-dione (1:1) [French] [ACD/IUPAC Name]
Complamin [Trade name]
Nicotinate de xantinol [French] [INN]
Nicotinato de xantinol [Spanish] [INN]
Nicotinic acid – 7-{2-hydroxy-3-[(2-hydroxyethyl)(methyl)amino]propyl}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione (1:1) [ACD/IUPAC Name]
Nicotinsäure –7-{2-hydroxy-3-[(2-hydroxyethyl)(methyl)amino]propyl}-1,3-dimethyl-3,7-dihydro-1H-purin-2,6-dion (1:1) [German] [ACD/IUPAC Name]
pyridine-3-carboxylic acid – 7-{2-hydroxy-3-[(2-hydroxyethyl)(methyl)amino]propyl}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione (1:1)
SK 331-A
UNII:8G60H12X2D
Xanthinol Niacinate [USAN]
Xanthinol nicotinate
Xantinol Niacinate
Xantinol nicotinate [INN] [Wiki]
Xantinol Nicotinate, (R)-
Xantinol Nicotinate, (S)-
Xantinoli nicotinas [Latin]
Xavin [Trade name]
ксантинола никотинат [Russian]
نيكوتينات كسانتينول [Arabic]
尼可占替诺 [Chinese]
[437-74-1]
{7-[2-Hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]theophylline,} compound with nicotinic acid (1:1)
108643-57-8 [RN]
3-Pyridinecarboxylic acid & {3,7-dihydro-7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]-1,} 3-dimethyl-1H-purine-2,6-dione (1:1)
3-Pyridinecarboxylic acid compd. with 3,7-dihydro-7-(2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl)-1,3-dimethyl-1H-purine-2,6-dione (1:1)
3-Pyridinecarboxylic acid compd. with 3,7-dihydro-7-[2-hydroxy-3-[ (2-hydroxyethyl)methylamino]propyl]-1, 3-dimethyl-1H-purine-2,6-dione (1:1)
3-Pyridinecarboxylic acid compd. with 3,7-dihydro-7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]-1,3-dimethyl-1H-purine-2,6-dione (1:1)
3-Pyridinecarboxylic acid, compd. with 3, {7-dihydro-7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]-1,} 3-dimethyl-1H-purine-2,6-dione (1:1)
3-Pyridinecarboxylic acid, compd. with 3, 7-dihydro-7-[2-hydroxy-3-[ (2-hydroxyethyl)methylamino]propyl]-1, 3-dimethyl-1H-purine-2,6-dione (1:1)
3-pyridinecarboxylic acid, compd. with 3,7-dihydro-7-[2-hydroxy-3-[(2-hydroxyethyl)(methyl)amino]propyl]-1,3-dimethyl-1H-purine-2,6-dione (1:1)
7- 2-Hydroxy-3-((2-hydroxyethyl)methylamino)propyl theophylline, compound with nicotinic acid (1:1)
7-(2-Hydroxy-3-((2-hydroxyethyl)(methyl)amino)propyl)-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione nicotinate
7-(2-Hydroxy-3-((2-hydroxyethyl)methylamino)propyl)theophylline compd. with nicotinic acid
7-(3-(N-(2-Hydroxyethyl)amino)-2-hydroxypropyl)thiophylline nicotinate
7-[2-Hydroxy-3-[ (2-hydroxyethyl)methylamino]propyl]theophylline, compound with nicotinic acid (1:1)
7-[2-hydroxy-3-[2-hydroxyethyl(methyl)amino]propyl]-1,3-dimethylpurine-2,6-dione
7-[2-hydroxy-3-[2-hydroxyethyl(methyl)amino]propyl]-1,3-dimethyl-purine-2,6-dione
7-[2-hydroxy-3-[2-hydroxyethyl(methyl)amino]propyl]-1,3-dimethylpurine-2,6-dione;pyridine-3-carboxylic acid
7-{2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl}-1,3-dimethyl-1,3,7-trihydr opurine-2,6-dione, pyridine-3-carboxylic acid
Angioamin
Angiomin
Complamex
Complamin retard
Contamex
Landrina
Methoxylin, compd. with nicotinic acid
MFCD00058342 [MDL number]
MFCD12923948 [MDL number]
min. 98%
Niacin [USAN] [USP] [Wiki]
NIACIN; XANTHINOL
nicotinic acid [INN] [ACD/IUPAC Name]
Nicotinic acid – 7-{2-hydroxy-3-[(2-hydroxyethyl)( methyl)amino]propyl}-1,3-dimethyl-3,7-dihydro-1H-p
Nicotinic acid – 7-{2-hydroxy-3-[(2-hydroxyethyl)-(methyl)amino]propyl}-1,3-dimethyl-3,7-dihydro-1H-p
Nicotinic acid compound with 7-(2-hydroxy-3-((2-hydroxyethyl)(methyl)amino)propyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione (1:1)
Nicotinic acid, compd. with {7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]theophylline} (1:1)
Nicotinic acid, compd. with 3,7-dihydro-7-(2-hydroxy-3-((2-hydroxyethyl) methylamino)propyl)-1,3-dimethyl-1H-purine-2,6-dione
Nicotinic acid, compd. with 7-(2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl)theophylline(1:1) (8CI)
Nicotinic acid, compd. with 7-[2-hydroxy-3-[ (2-hydroxyethyl)methylamino]propyl]theophylline (1:1)
Nicotinic acid, compd. with 7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]theophylline (1:1)
NICOTINIC ACID-7-{2-HYDROXY-3-[(2-HYDROXYETHYL)(METHYL)AMINO]PROPYL}-1,3-DIMETHYL-3,7-DIHYDRO-1H-P
Pyridine-3-carboxylic acid [ACD/IUPAC Name]
QA-7530
Sadamin
Sadamine
SK 331 A
SK 331A
Stenalgil
Teonicol
Vedrin
Xanidil
Xanthinol [Wiki]
Xanthinolium nicotinicum
Xantinolo nicotinato [DCIT]
SMILES
Cn1c2c(c(=O)n(c1=O)C)n(cn2)CC(CN(C)CCO)O.c1cc(cnc1)C(=O)O
StdInChI
InChI=1S/C13H21N5O4.C6H5NO2/c1-15(4-5-19)6-9(20)7-18-8-14-11-10(18)12(21)17(3)13(22)16(11)2;8-6(9)5-2-1-3-7-4-5/h8-9,19-20H,4-7H2,1-3H3;1-4H,(H,8,9)
StdInChIKey
GEPMAHVDJHFBJI-UHFFFAOYSA-N
Molecular Formula
C19H26N6O6
Molecular Weight
434.446
MDL Number
MFCD00058342
Properties
Appearance
White crystalline powder
Melting Point
180° – 185° C
Safety Data
WGK Germany
3
Specifications and Other Information of Our Xanthinol Nicotinate CAS 437-74-1
Assay
≥98.5 %
Loss on Drying
≤0.5 %
Known Application
Nicotinic acid is suitable for the treatment of cerebrovascular disorders (such as cerebral thrombosis, cerebral embolism, sequelae of brain trauma, sequelae of brain surgery, sequelae of stroke, hypoxic cerebral softening caused by carotid artery occlusion, and elderly brain dysfunction Etc.), coronary heart disease, angina, myocardial infarction (prevention of recurrence), myocarditis, migraine, auricular vertigo, acral arterial spasm, intermittent claudication, diabetic gangrene, thrombophlebitis, varicose veins Ulcers, pulmonary embolism, hemorrhoids, frostbite and hyperlipidemia.